News & Events

Ensuring accurate classification of BRCA variants - Registration now open!

Invitation to participate

Individual assessment of pathogenicity classification of BRCA1 and BRCA2 variants developed for you!
UK NEQAS for Molecular Genetics have launched an educational tool for BRCA variant classification and we invite members of your clinical service to participate.
The aim of this EQA scheme is to provide an online competency assessment for the classification of BRCA1 and BRCA2 gene variants related to ovarian cancer and the predicted response to PARP inhibitor treatment. This EQA is open to individuals who classify the pathogenicity of variants and provides assurance of your competency to achieve this accurately and in the most up-to-date manner.
Details about this exciting new module are available here -  BRCA variants - invitation to participate 2017 v1.pdf 
Registration is now open and easy to complete. To access the registration form please follow this link 

  • There is no fee to participate as Astra Zeneca will cover your participation costs. Please note that Astra Zeneca will not be provided with your identified EQA results.
  • The closing date for registrations is 31st October 2017.